The National Cancer Institute (NCI) awarded a $14,670 purchase order to Yokogawa Corporation of America, doing business as Dixon Industrial Sales, for the purchase of a replacement OEM 40x water objective for a Yokogawa CV8000 high-content screening system. This firm fixed-price contract has an ultimate completion date of September 11, 2024 and does not have a set-aside designation. Yokogawa is a foreign-owned, for-profit manufacturer of specialized test and measurement equipment that has provided various instruments and services to U.S. federal agencies, including the Departments of Health and Human Services, Defense, Energy, and Commerce, as well as NASA, through both prime and subcontract awards.
Generated 7/26/24, 9:52 AM